R6	Coref Anaphora:T25 Antecedent:T40
T41	SPAN 519 541	RAR(alpha) and PML-RAR
R7	Coref Anaphora:T27 Antecedent:T41
R8	Coref Anaphora:T33 Antecedent:T14
T1	Protein 39 73	retinoic-acid receptors type alpha
T2	Protein 381 414	retinoic-acid receptor type alpha
T3	Protein 416 426	RAR(alpha)
T4	Protein 436 476	leukemia-specific retinoic acid receptor
T5	Protein 477 484	PML-RAR
T6	Protein 519 529	RAR(alpha)
T7	Protein 534 541	PML-RAR
T8	Protein 642 652	RAR(alpha)
T9	Protein 657 664	PML-RAR
T10	Protein 804 850	granulocyte-colony-stimulating factor receptor
T11	Protein 860 890	leukocyte alkaline phosphatase
T12	Protein 1006 1011	CD11b
T13	Protein 1016 1020	CD33
T14	Protein 1052 1062	RAR(alpha)
T15	Protein 1192 1199	PML-RAR
T40	Exp 486 511	Transcriptional induction
T21	Exp 129 142	the induction
T22	Exp 204 247	the acute promyelocytic (APL) cell line NB4
T23	Exp 354 369	the transcripts
T24	Exp 432 476	the leukemia-specific retinoic acid receptor
T25	Exp 561 563	it
T26	Exp 515 529	the RAR(alpha)
T27	Exp 597 623	the corresponding proteins
T28	Exp 738 751	the induction
T29	Exp 941 974	the retinoid-dependent regulation
T30	Exp 978 1011	the myeloid surface markers CD11b
T31	Exp 1022 1048	The IFN-dependent increase
T32	Exp 1074 1094	the enhancing effect
T33	Exp 1098 1110	the cytokine
T34	Exp 1222 1235	the phenomena
T35	Exp 1318 1328	the growth
T36	Exp 1352 1365	the 2 classes
T37	Exp 1472 1488	the possible use
T38	Exp 1539 1573	the cyto-differentiating treatment
T39	Exp 1450 1463	These results
